Literature DB >> 22266152

Autoimmunity, intestinal lymphoid hyperplasia, and defects in mucosal B-cell homeostasis in patients with PTEN hamartoma tumor syndrome.

Mario Heindl1, Norman Händel, Joanne Ngeow, Janina Kionke, Christian Wittekind, Manja Kamprad, Anne Rensing-Ehl, Stephan Ehl, Julia Reifenberger, Christoph Loddenkemper, Jochen Maul, Albrecht Hoffmeister, Stefan Aretz, Wieland Kiess, Charis Eng, Holm H Uhlig.   

Abstract

The Phosphatase And Tensin Homolog Deleted On Chromosome 10 (PTEN) regulates the phosphoinositol-3-kinase (PI3K)-AKT signaling pathway. In a series of 34 patients with PTEN mutations, we described gastrointestinal lymphoid hyperplasia, extensive hyperplastic tonsils, thymus hyperplasia, autoimmune lymphocytic thyroiditis, autoimmune hemolytic anemia, and colitis. Functional analysis of the gastrointestinal mucosa-associated lymphoid tissue revealed increased signaling via the PI3K-AKT pathway, including phosphorylation of S6 and increased cell proliferation, but also reduced apoptosis of CD20(+)CD10(+) B cells. Reduced activity of PTEN therefore affects homeostasis of human germinal center B cells by increasing PI3K-AKT signaling via mammalian target of rapamycin as well as antiapoptotic signals.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266152     DOI: 10.1053/j.gastro.2012.01.011

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  29 in total

Review 1.  Gut microbiome and chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Hans C Arora; Charis Eng; Daniel A Shoskes
Journal:  Ann Transl Med       Date:  2017-01

Review 2.  IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironment.

Authors:  David H Munn; Madhav D Sharma; Theodore S Johnson; Paulo Rodriguez
Journal:  Cancer Immunol Immunother       Date:  2017-05-09       Impact factor: 6.968

3.  Intermediate uveitis in a child with phosphatase and tensin homolog gene mutation and Bannayan-Riley-Ruvalcaba syndrome.

Authors:  Daphna Prat; Iris Ben Bassat Mizrachi; Vicktoria Vishnevskia-Dai
Journal:  BMJ Case Rep       Date:  2019-02-12

Review 4.  PTEN-opathies: from biological insights to evidence-based precision medicine.

Authors:  Lamis Yehia; Joanne Ngeow; Charis Eng
Journal:  J Clin Invest       Date:  2019-01-07       Impact factor: 14.808

5.  Germline PTEN mutations are associated with a skewed peripheral immune repertoire in humans and mice.

Authors:  Ritika Jaini; Matthew G Loya; Alexander T King; Stetson Thacker; Nicholas B Sarn; Qi Yu; George R Stark; Charis Eng
Journal:  Hum Mol Genet       Date:  2020-08-11       Impact factor: 6.150

Review 6.  IL-37: An anti-inflammatory cytokine with antitumor functions.

Authors:  Yu Mei; Haiyan Liu
Journal:  Cancer Rep (Hoboken)       Date:  2018-11-22

7.  Increased prevalence of eosinophilic gastrointestinal disorders in pediatric PTEN hamartoma tumor syndromes.

Authors:  Carol J Henderson; Joanne Ngeow; Margaret H Collins; Lisa J Martin; Philip E Putnam; Juan P Abonia; Keith Marsolo; Charis Eng; Marc E Rothenberg
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-05       Impact factor: 2.839

8.  Effect of adenovirus-mediated PTEN gene on ulcerative colitis-associated colorectal cancer.

Authors:  Zhi Li; Gong Xiang Liu; Yu Lan Liu; Xi Chen; Xiao Li Huang; Hua Tian Gan
Journal:  Int J Colorectal Dis       Date:  2013-03-21       Impact factor: 2.571

Review 9.  PTEN in Hereditary and Sporadic Cancer.

Authors:  Joanne Ngeow; Charis Eng
Journal:  Cold Spring Harb Perspect Med       Date:  2020-04-01       Impact factor: 6.915

10.  Epithelial Control of Gut-Associated Lymphoid Tissue Formation through p38α-Dependent Restraint of NF-κB Signaling.

Authors:  Celia Caballero-Franco; Monica Guma; Min-Kyung Choo; Yasuyo Sano; Thomas Enzler; Michael Karin; Atsushi Mizoguchi; Jin Mo Park
Journal:  J Immunol       Date:  2016-01-20       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.